Literature DB >> 30762604

Floor and ceiling effects of the World Health Organization Disability Assessment Schedule 2.0 among patients with chronic musculoskeletal pain.

Niina Katajapuu1, Katri Laimi2, Ari Heinonen1, Mikhail Saltychev2.   

Abstract

The aim of this study was to investigate the floor and ceiling effects of 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS). This was a cross-sectional survey study at a university's physical and rehabilitation medicine outpatient clinic of 1988 patients with chronic musculoskeletal pain. Floor and ceiling effects were calculated as relative frequencies of the lowest or the highest possible scores for each item. The probit plotting method was used to detect the non-normality of distribution of the total score graphically. A significant floor effect of 15-79% was observed in all 12 WHODAS 2.0 items. A substantial floor effect for total score was also detected graphically. No ceiling effects were observed. In this study, a significant floor effect was found for all WHODAS 2.0 items among patients with chronic musculoskeletal pain associated with mild or no disability.

Entities:  

Mesh:

Year:  2019        PMID: 30762604     DOI: 10.1097/MRR.0000000000000339

Source DB:  PubMed          Journal:  Int J Rehabil Res        ISSN: 0342-5282            Impact factor:   1.479


  4 in total

1.  Minimal clinically important difference and minimal detectable change of the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) amongst patients with chronic musculoskeletal pain.

Authors:  Niina Katajapuu; Ari Heinonen; Mikhail Saltychev
Journal:  Clin Rehabil       Date:  2020-07-27       Impact factor: 3.477

2.  Validity Evidence of the eHealth Literacy Questionnaire (eHLQ) Part 2: Mixed Methods Approach to Evaluate Test Content, Response Process, and Internal Structure in the Australian Community Health Setting.

Authors:  Christina Cheng; Gerald R Elsworth; Richard H Osborne
Journal:  J Med Internet Res       Date:  2022-03-08       Impact factor: 7.076

3.  Comparison of the responsiveness of the WOMAC and the 12-item WHODAS 2.0 in patients with Kashin-Beck disease.

Authors:  Lei Yang; Dimiao Wang; Xiuxia Li; Hangjing Yuan; Hua Fang; Xiong Guo
Journal:  BMC Musculoskelet Disord       Date:  2020-03-25       Impact factor: 2.362

4.  Psychometric properties and validation of the polish version of the 12-item WHODAS 2.0.

Authors:  Agnieszka Ćwirlej-Sozańska; Bernard Sozański; Hubert Kotarski; Anna Wilmowska-Pietruszyńska; Agnieszka Wiśniowska-Szurlej
Journal:  BMC Public Health       Date:  2020-08-05       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.